STENOCARE A/S (“Stenocare”) announces additional financing and imminent scale up of sales
STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO In preparation of the extraordinary general meeting this week on Friday November 18, 2022, Stenocare is pleased to confirm its sales guidance and to announce additional financing, which is expected to cover the company’s funding needs until the anticipated break-even by end of 2023.This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The information was provided by the contact person below for publication on November 15, 2022. Further funding